BASL Winter Meeting and Liver Course

08:30 – 09:00 Registration

9:00 - 12:30 Liver Course

09:00 – 10.30  Session 1: Pathophysiology and diagnosis of MASLD

1. Pathophysiology of MASLD – Bart Staels (University of Lille, France)
2. Non-invasive tests for diagnosis and prognosis – Nicolas Lanthier (UCL)
3. Pediatric MASLD: updates in screening and diagnosis – Jake Mann (University of Birmingham, United Kingdom)

10:30 – 10:45: Coffee break

11.00 – 12.30 Session 2: Treatment aspects of MASLD

1. Obesity, bariatric surgery and alcohol – Anja Geerts (UZ Gent)
2. Metabolic treatment as indirect liver therapy – Bart van der Schueren (UZ Leuven)
3. Liver-direct therapies – Sven Francque (UZA)

12:30 – 13:30 Lunch break

13:30  - 17:00 General Hepatology Course

13:30 – 15:00 Session 1

1. Managing bleeding in cirrhotic patients - Wim Laleman (UZ Leuven), Pierre Deltenre (Saint-Luc Bouge and HUB) and Lukas Van Melckebeke (UZ Leuven)
2. Practical approach to the management of hepatitis B and C – Odile Warling (CHU de Liège), Thomas Vanwolleghem (UZA) and Marie Coessens (UZA)

15:00 – 15:15: Coffee break

15:15 – 17:00 Session 2

1. Practical approach to cholestasis - Helena Degroote (UZ Brussel), Laura Weichselbaum (HUB) and Lander Heyerick (UZ Gent)
2. When to transplant - Geraldine Dahlquist (UCL), Hans Van Vlierberghe (UZ Gent) and Guillaume Henin (UCL)

08:30 – 09:00 Registration

09:00 – 10.15  Session 1: Hepatology update

1. Beneficial and side effects of GLP1 agonists – Sven Francque (UZA)
2. Gut microbiota and liver disease – Bernd Schnabl (University of California San Diego, USA)
    

10:15 – 10:45: Coffee break

10:45 – 12.00 Session 2: Non-interactive discussion of clinical cases

12:00 - 12:15 Presentations of BASL YOUNG INVESTIGATORS AWARDS LAUREATES 2025 and short presentation by 2024 Laureates (Pierre Deltenre)

12:15 – 12:30 BASL awards for the best clinical and basic publications 2024 (Pierre Deltenre)

12:30 – 13:30 Lunch break

13:30 – 15:30 Session 3: Medications in liver disease

1. Albumin in chronic liver diseases: current and expending indications - Paolo Caraceni (University of Bologna, Italy)
2. Treating portal hypertension: always carvedilol? – Wim Laleman (KU Leuven)
3. Statins old drugs as new therapy for liver diseases? - Ulrich Beuers (University of Amsterdam, Netherlands)
    

15:30 – 16:00: Coffee break

16:00 – 17:00 Past president talks

1. History of hepatology, advancements in the field and practices – Jean Henrion (Jolimont)
2. Big mistakes in hepatology – Isabelle Colle (Azorg)